Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-04-22 4:05 pm Purchase |
2022-04-12 | 13G | Lyra Therapeutics, Inc. LYRA |
Venrock Healthcare Capital Partners II, L.P. | 3,433,050 9.999% |
3,433,050 (New Position) |
Filing History |
| 2022-04-21 4:05 pm Purchase |
2022-04-11 | 13G | Trevi Therapeutics, Inc. TRVI |
Venrock Healthcare Capital Partners II, L.P. | 3,668,334 9.990% |
3,668,334 (New Position) |
Filing History |
| 2022-02-14 4:21 pm Purchase |
2021-12-31 | 13G | Sierra Oncology, Inc. SRRA |
Venrock Healthcare Capital Partners II, L.P. | 984,746 6.100% |
979,565 (+18907.15%) |
Filing History |
| 2022-02-14 4:20 pm Sale |
2021-12-31 | 13G | Altimmune, Inc. ALT |
Venrock Healthcare Capital Partners II, L.P. | 1,760,870 4.200% |
-1,862,094 (-51.40%) |
Filing History |
| 2022-02-14 4:20 pm Purchase |
2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Venrock Healthcare Capital Partners II, L.P. | 534,910 8.000% |
60,235 (+12.69%) |
Filing History |
| 2022-02-14 4:19 pm Purchase |
2021-11-17 | 13G | TRICIDA INC TCDAQ |
Venrock Healthcare Capital Partners II, L.P. | 3,494,851 6.300% |
3,494,851 (New Position) |
Filing History |
| 2022-02-14 4:19 pm Purchase |
2021-03-26 | 13G | Relmada Therapeutics, Inc. RLMD |
Venrock Healthcare Capital Partners II, L.P. | 2,270,072 8.200% |
1,601,632 (+239.61%) |
Filing History |
| 2022-02-14 4:18 pm Purchase |
2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Venrock Healthcare Capital Partners II, L.P. | 2,880,096 7.800% |
291,155 (+11.25%) |
Filing History |
| 2022-02-14 4:17 pm Sale |
2021-12-31 | 13G | aTyr Pharma, Inc. ATYR |
Venrock Healthcare Capital Partners II, L.P. | 1,565,000 5.600% |
-250,000 (-13.77%) |
Filing History |
| 2022-02-14 4:15 pm Sale |
2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Venrock Healthcare Capital Partners II, L.P. | 250,000 0.500% |
-3,177,461 (-92.71%) |
Filing History |
| 2022-02-14 4:14 pm Purchase |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Venrock Healthcare Capital Partners II, L.P. | 4,302,126 9.990% |
4,302,126 (New Position) |
Filing History |
| 2022-02-14 4:14 pm Sale |
2021-12-31 | 13G | Athira Pharma, Inc. ATHA |
Venrock Healthcare Capital Partners II, L.P. | 1,000,000 2.700% |
-691,623 (-40.89%) |
Filing History |
| 2022-02-14 4:13 pm Purchase |
2021-01-19 | 13G | Aclaris Therapeutics, Inc. ACRS |
Venrock Healthcare Capital Partners II, L.P. | 4,563,962 7.500% |
4,563,962 (New Position) |
Filing History |
| 2022-02-14 4:13 pm Purchase |
2021-08-26 | 13G | Aadi Bioscience, Inc. AADI |
Venrock Healthcare Capital Partners II, L.P. | 1,529,402 7.300% |
1,529,402 (New Position) |
Filing History |
| 2021-11-10 4:05 pm Purchase |
2021-10-31 | 13G | LianBio LIANY |
Venrock Healthcare Capital Partners II, L.P. | 5,378,341 5.100% |
5,378,341 (New Position) |
Filing History |
| 2021-09-30 4:05 pm Purchase |
2021-09-20 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Venrock Healthcare Capital Partners II, L.P. | 3,427,461 8.100% |
3,427,461 (New Position) |
Filing History |
| 2021-09-27 5:14 pm Purchase |
2021-09-16 | 13G | aTyr Pharma, Inc. ATYR |
Venrock Healthcare Capital Partners II, L.P. | 1,815,000 6.700% |
1,815,000 (New Position) |
Filing History |
| 2021-06-07 4:30 pm Purchase |
2021-05-26 | 13G | Provention Bio, Inc. PRVB |
Venrock Healthcare Capital Partners II, L.P. | 3,843,796 6.100% |
3,843,796 (New Position) |
Filing History |
| 2021-04-15 4:09 pm Purchase |
2021-03-23 | 13G | Instil Bio, Inc. TIL |
Venrock Healthcare Capital Partners II, L.P. | 343,254 5.400% |
343,254 (New Position) |
Filing History |
| 2021-03-01 4:07 pm Sale |
2021-02-25 | 13G | Altimmune, Inc. ALT |
Venrock Healthcare Capital Partners II, L.P. | 3,622,964 9.990% |
-877,036 (-19.49%) |
Filing History |